Bio-Medical Applications Of Alabama, Inc. in Anniston, Alabama - Dialysis Center

Bio-Medical Applications Of Alabama, Inc. is a medicare approved dialysis facility center in Anniston, Alabama and it has 10 dialysis stations. It is located in Calhoun county at 2017 Quintard Ave, Suite B, Anniston, AL, 36201. You can reach out to the office of Bio-Medical Applications Of Alabama, Inc. at (256) 235-2452. This dialysis clinic is managed and/or owned by Fresenius Medical Care. Bio-Medical Applications Of Alabama, Inc. has the following ownership type - Profit. It was first certified by medicare in December, 2015. The medicare id for this facility is 012682 and it accepts patients under medicare ESRD program.

Dialysis Center Profile

NameBio-Medical Applications Of Alabama, Inc.
Location2017 Quintard Ave, Suite B, Anniston, Alabama
No. of Dialysis Stations 10
Medicare ID012682
Managed ByFresenius Medical Care
Ownership TypeProfit
Late Shifts No

Contact Information


2017 Quintard Ave, Suite B, Anniston, Alabama, 36201
(256) 235-2452

Map and Direction



NPI Associated with this Dialysis Facility:

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Bio-Medical Applications Of Alabama, Inc. from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number1679951974
Organization NameFresenius Medical Care Anniston North
Doing Business AsBio-medical Applications Of Alabama, Inc.
Address2017 Quintard Ave Anniston, Alabama, 36201
Phone Number(256) 235-2925

Patient Distribution

Anemia Management

Dialysis patients with Hemoglobin data11
Medicare patients who had average hemoglobin (hgb) less than 10 g/dL9

Dialysis Adequacy

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

  • Hemodialysis
    Adult patients getting regular hemodialysis at the center23
    Adult patient months included in Kt/V greater than or equal to 1.2229
    Percentage of adult patients getting regular hemodialysis at the center99
    Percentage of pediatric patients getting regular hemodialysis at the center

Mineral and Bone Disorder

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Bio-Medical Applications Of Alabama, Inc. with elevated calcium levels.

Patients with hypercalcemia23
Hypercalcemia patient months229
Patients with Serumphosphor23
Patients with Serumphosphor less than 3.5 mg/dL13
Patients with Serumphosphor from 3.5 to 4.5 mg/dL20
Patients with Serumphosphor from 4.6 to 5.5 mg/dL26
Patients with Serumphosphor from 5.6 to 7 mg/dL24
Patients with Serumphosphor greater than 7 mg/dL16

Vascular Access

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries 20
Patient months included in arterial venous fistula and catheter summaries 170
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment49
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer2

Hospitalization Rate

The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.

Standard Hospitalization Summary Ratio(SHR) YearJanuary, 2016 - December, 2016
Patients in facility's Hospitalization Summary17
Hospitalization Rate in facility269.6 (As Expected)
Hospitalization Rate: Upper Confidence Limit669
Hospitalization Rate: Lower Confidence Limit116.7

Readmission Rate

The rate of readmission show you whether patients who were being treated regularly at Bio-Medical Applications Of Alabama, Inc. were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.

Standard Readmission Summary Ratio(SRR) YearJanuary, 2016 - December, 2016
Readmission Rate in facility15 (As Expected)
Readmission Rate: Upper Confidence Limit33.5
Readmission Rate: Lower Confidence Limit4.5